Total Payments
$113,627
2024 Payments
$365.27
Companies
12
Transactions
292
Medicare Patients
788
Medicare Billing
$7,283
Payment Breakdown by Category
Other$81,745 (71.9%)
Travel$21,013 (18.5%)
Food & Beverage$8,702 (7.7%)
Consulting$1,680 (1.5%)
Education$486.15 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $81,745 | 54 | 71.9% |
| Travel and Lodging | $21,013 | 47 | 18.5% |
| Food and Beverage | $8,702 | 179 | 7.7% |
| Consulting Fee | $1,680 | 2 | 1.5% |
| Education | $486.15 | 10 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $87,108 | 159 | $0 (2024) |
| AbbVie Inc. | $23,744 | 55 | $0 (2021) |
| ViiV Healthcare Company | $1,220 | 34 | $0 (2024) |
| Janssen Products, LP | $819.85 | 10 | $0 (2021) |
| Janssen Biotech, Inc. | $391.24 | 21 | $0 (2023) |
| GlaxoSmithKline, LLC. | $133.87 | 2 | $0 (2018) |
| Janssen Scientific Affairs, LLC | $47.04 | 2 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $45.01 | 3 | $0 (2019) |
| Napo Pharmaceuticals Inc | $43.04 | 3 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $28.48 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $365.27 | 5 | ViiV Healthcare Company ($243.67) |
| 2023 | $11,492 | 27 | Gilead Sciences, Inc. ($11,204) |
| 2022 | $5,354 | 19 | Gilead Sciences, Inc. ($5,249) |
| 2021 | $10,706 | 24 | Gilead Sciences, Inc. ($9,553) |
| 2020 | $8,513 | 24 | Gilead Sciences, Inc. ($8,297) |
| 2019 | $34,251 | 83 | Gilead Sciences, Inc. ($22,832) |
| 2018 | $23,362 | 51 | Gilead Sciences, Inc. ($15,090) |
| 2017 | $19,583 | 59 | Gilead Sciences Inc ($14,762) |
All Payment Transactions
292 individual payment records from CMS Open Payments — Page 3 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/19/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.01 | General |
| 12/27/2021 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $420.00 | General |
| Category: HIV | ||||||
| 12/13/2021 | Janssen Pharmaceuticals, Inc | — | Education | In-kind items and services | $28.48 | General |
| 12/07/2021 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 11/30/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $100.00 | General |
| 11/11/2021 | Gilead Sciences, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,730.00 | General |
| 11/09/2021 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $758.72 | General |
| 11/09/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $97.65 | General |
| 10/19/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.44 | General |
| 09/14/2021 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 09/01/2021 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: HIV | ||||||
| 07/28/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.81 | General |
| 07/06/2021 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: HIV | ||||||
| 07/01/2021 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,730.00 | General |
| Category: HIV | ||||||
| 06/29/2021 | AbbVie Inc. | MAVYRET (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: VIROLOGY | ||||||
| 06/28/2021 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $607.47 | General |
| Category: HIV | ||||||
| 06/28/2021 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $79.87 | General |
| Category: HIV | ||||||
| 06/16/2021 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 05/28/2021 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,660.00 | General |
| Category: HIV | ||||||
| 04/16/2021 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: HIV | ||||||
| 04/15/2021 | Janssen Products, LP | SYMTUZA (Drug) | Education | In-kind items and services | $85.00 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 04/05/2021 | Gilead Sciences, Inc. | Epclusa (Drug) | Consulting Fee | Cash or cash equivalent | $1,430.00 | General |
| Category: HCV | ||||||
| 03/29/2021 | Gilead Sciences, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $860.00 | General |
| 03/26/2021 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: HIV | ||||||
| 03/11/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.63 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 13 | 13 | $1,625 | $136.58 |
| 2022 | 1 | 19 | 19 | $2,375 | $307.55 |
| 2021 | 4 | 756 | 765 | $11,144 | $6,839 |
Total Patients
788
Total Services
797
Medicare Billing
$7,283
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92250 | Photography of the retina | Office | 2023 | 13 | 13 | $1,625 | $136.58 | 8.4% |
| 92250 | Photography of the retina | Office | 2022 | 19 | 19 | $2,375 | $307.55 | 12.9% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 365 | 365 | $9,215 | $6,471 | 70.2% |
| 92250 | Photography of the retina | Office | 2021 | 13 | 13 | $1,625 | $297.09 | 18.3% |
| 82947 | Blood glucose (sugar) level | Office | 2021 | 11 | 17 | $119.00 | $66.81 | 56.1% |
| 91301 | Sarscov2 vac 100mcg/0.5ml im | Office | 2021 | 367 | 370 | $185.00 | $3.70 | 2.0% |
About Dr. Sapna Chowdhry, MD
Dr. Sapna Chowdhry, MD is a Internal Medicine healthcare provider based in Woonsocket, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902843311.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sapna Chowdhry, MD has received a total of $113,627 in payments from pharmaceutical and medical device companies, with $365.27 received in 2024. These payments were reported across 292 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($81,745).
As a Medicare-enrolled provider, Chowdhry has provided services to 788 Medicare beneficiaries, totaling 797 services with total Medicare billing of $7,283. Data is available for 3 years (2021–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Infectious Disease
- Location Woonsocket, RI
- Active Since 06/02/2006
- Last Updated 06/23/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1902843311
Products in Payments
- Biktarvy (Drug) $27,276
- Mavyret (Drug) $22,790
- Genvoya (Drug) $6,842
- Epclusa (Drug) $1,545
- MAVYRET (Drug) $953.85
- DOVATO (Drug) $554.79
- PREZCOBIX (Drug) $488.39
- Symtuza (Drug) $404.71
- APRETUDE (Biological) $320.22
- SYMTUZA (Drug) $226.43
- JULUCA (Drug) $172.98
- Descovy (Drug) $143.79
- SHINGRIX (Biological) $133.87
- Truvada (Drug) $127.14
- TRIUMEQ (Drug) $87.34
- CABENUVA (Biological) $84.89
- ISENTRESS (Drug) $45.01
- Mytesi (Drug) $43.04
- EDURANT (Drug) $30.47
- VIBERZI (Drug) $23.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Woonsocket
Dr. Ibrahim Elgabry, M.d, M.D
Internal Medicine — Payments: $147,921
Internal Medicine $147,921
Dr. Greigstone Yearwood, M.d, M.D
Internal Medicine — Payments: $8,093
Internal Medicine $8,093
Dr. Irfan Ahmad, M.d, M.D
Internal Medicine — Payments: $4,470
Internal Medicine $4,470
Dr. Jibran Khan, M.d, M.D
Internal Medicine — Payments: $3,501
Internal Medicine $3,501
Deborah Rich, Md, MD
Internal Medicine — Payments: $3,372
Internal Medicine $3,372
Dr. Stanley Balon, M.d, M.D
Internal Medicine — Payments: $1,925
Internal Medicine $1,925